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Supplementary Information
General.
Protected amino acids Fmoc-L-Dap(Boc)-OH and Fmoc-L-Orn(Boc)-OH were 
purchased from Chemimpex, and, Fmoc-L-Dab(Boc)-OH  from GL Biochem. 
Solvents and other reagents were purchased from Sigma Aldrich and used without 
further purification. Biotage Initiator Eight microwave reactor system was used for all 
reactions. Jasco P1010 Polarimeter was used to measure optical rotation. Analytical 
LC/MS was performed on an Agilent 1200 Series system with a single quadrupole 
mass spectrometer (6110), a UV detector operating at 210 nm and an ELSD detector, 
and using an analytical reverse phase column (Eclipse XDB-Phenyl, 5 m, 4.6x150 
mm), flow rate 1 mL/min. Alternatively LCMS analysis was performed using a 
Shimadzu Prominence system using an Agilent Zorbax Eclipse XDB-Phenyl column 
maintained at 40ºC with SPD-M20A diode array UV-Vis detector, ELSD –LT II 
evaporative light scattering detector and LCMS-2020 mass spectrometer. Reverse 
phase eluent for analytical purposes was effected using an appropriate gradient from 
water (0.05% formic acid) and acetonitrile (0.05% formic acid), flow rate of 1 
ml/min. High resolution mass spectra were obtained on a Bruker micrOTOF 232. 
NMR spectra were obtained on a Bruker 600 MHz.
Experimental Procedures. 
Synthesis of 4, 7 and 8:
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Example of 4:
To Fmoc-L-Dab(Boc)-OH (2 mmol, 881 mg) in a microwave reactor tube with a 
magnetic stirrer, was added solid paraformaldehyde (4 mmol, 133 mg), 
camphorsulfonic acid (0.17 mmol, 40 mg, 8.6mol%) and acetonitrile (10 mL). The 
tube was then sealed and subjected to a 2 min run at 120 °C (microwave settings at 
400 Watts). Resulting cooled mixture was concentrated under vacuo and put through 
a short silica pad using ethyl acetate and petroleum spirits (3:7) as eluent, dried with 
MgSO4 and finally concentrated under vacuo to give a colourless oily residue. 
Lyophilisation from water/acetonitrile (1:1) yields a white powder of respective 
compound 4, 7 and 8. The powders of compounds 4, 7 and 8 are air sensitive and 
become oils within minutes and thus requires N2 atmosphere or cooled conditions for 
storage.
4: FL_7023_74_1 (Trans/Cis isomers) 1H NMR (600 MHz, CDCl3): 1.48 (br, s, 9H); 
2.00-2.22 (br, m, 2H); 2.96, 3.09, 3.95 (br, 2H); 4.22-4.38 (br, m, 1H); 4.40-4.50 (br, 
2H); 4.64 (br, 1H); 5.00 (br, 1H); 7.34 (m, 2H); 7.39 (br, 2H); 7.51 (br, m, 1H); 7.62 
(br, 1H); 7.76 (br, 2H). 13C NMR (150.9 MHz, CDCl3): 25.6 (s), 28.3 (s), 39.6 (br), 
47.0 (s), 53.0 (s), 67.5 (s), 68.5 (br), 80.9 (s), 119.9 (s), 124.9 (s), 127.2 (s), 128.1 (s), 
141.4 (s), 143.7 (s), 154.0 (br), 155.2 (s), 175.4 (br, s). MS: m/z 453 [M+H]+, 353 [M-
Boc]+. HRMS calculated for C25H28N2O6Na: 475.1840. Found 475.1860. 
7: FL_7292_36_1 (Trans/Cis at Fmoc amide bond) 1H NMR (600 MHz, CDCl3): 1.49 
(s, 9H); 3.78, 3.98 (m, 2H); 4.20, 4.30 (m, 1H); 4.38, 4.67 (m, 1H); 4.44, 4.54 (m, 
2H); 4.78, 4.84 (m, 2H); 7.33 (m, 2H); 7.41 (t, 2H); 7.54 (m, 2H); 7.56 (m, 2H); 7.74 
(m, 2H); 7.78 (m, 2H). 13C NMR (150.9 MHz, CDCl3): 28.2 (s), 47.0 (br), 47.1 (s), 
48.0 (br), 56.3 (br), 60.2 (s), 67.8 (s), 120.1 (s), 124.8 (d), 125.0 (d), 127.1 (s), 127.8 
(s), 127.9 (s), 141.3 (s), 143.5 (m), 152.8 (s), 173.4 (s). MS: m/z 439 [M+H]+, 339 
[M-Boc]+. HRMS calculated for C24H26N2O6Na: 461.1683. Found 461.1699.
8: FL-7292-35-1 1H NMR (600 MHz, CDCl3): 1.46 (br, s, 9H); 1.76, 1.86 (br, m, 
2H); 2.09, 2.24 (br, m, 2H); 3.29, 3.51 (br, m, 2H); 4.2-4.35 (br, 1H); 4.47, 4.77 (br, 
1H); 4.51 (m, 2H); 4.97-5.19 (m, 2H); 7.35 (br, 2H); 7.43 (br, 2H); 7.58 (br, 2H); 7.79 
(br, 2H). 13C NMR (150.9 MHz, CDCl3): 25.7 (s), 27.5 (s), 28.2 (br), 46.4 (s), 47.1 
(s), 57.6 (s), 58.1 (s), 67.7 (s), 120.0 (s), 125.1 (s), 127.0 (s), 127.8 (s). MS: m/z 467 
[M+H]+, 367 [M-Boc]+. HRMS calculated for C26H31N2O6: 467.2177. Found 
467.2165. 
Synthesis of 9 – 11:
Example of 10:
To crude 4 (2.2 mmol, 100 mg) in a 1 mL vial with a stirrer bar was added 
triethylsilane (12 mmol, 0.2 mL), trifluoroacetic acid (0.2 mL) and chloroform (0.2 
mL). The mixture was sealed and stirred for 8 h at ambient temperature. LCMS 
analysis revealed full conversion of starting material and addition of a new single 
peak corresponding to the desired product. The crude mixture was then concentrated 
under vacuo followed by drying on a high vacuum set up (~2 h) to yield 75 mg (96 
%) of a bright yellow oil. Compounds 9 and 11 required 8 h at 60 °C for complete 
conversion. Lyophilisation from water/acetonitrile (1:1) yields a white powder of 
respective compound 9 - 11. The powders of compounds 9 – 11 are air sensitive and 
become oils within minutes and thus requires N2 atmosphere or cooled conditions for 
storage.
9: FL_7292_51_8_14 1H NMR (600 MHz, CDCl3): 2.16-2.21 (br, m, 2H); 2.67 (s, 
3H); 3.04, 3.17 (br, m, 2H); 4.15 (br, 1H); 4.33 (br, m, 1H); 4.20 (t, J = 6.92 Hz, 2H); 
4.35 (d, J = 6.92 Hz, 2H); 6.33 (d, 3J = 4.67 Hz, 1H); 7.30 (t, J = 7.52 Hz, 2H); 7.40 
(t, J = 7.52 Hz, 2H); 7.60 (t, J = 8.20 Hz, 2H); 7.80 (d, J = 7.50 Hz, 2H). 13C NMR 
(150.9 MHz, CDCl3): 30.2 (s), 33.3 (s), 47.1 (s), 47.7 (s), 54.2 (s), 67.2 (s), 120.3 (s), 
125.2 (s), 127.1 (s), 127.8 (s), 141.3 (s), 143.8 (s), 144.0 (s), 156.6 (s), 176.0 (s). MS: 
m/z 355 [M+H]+. HRMS calculated for C20H23N2O4: 355.1652. Found 355.1643. 
[]D20 +200.74 (c 0.033, CHCl3)
10: FL_7292_52_10_14 1H NMR (600 MHz, DMSO-d6): 2.54 (s, 6H); 2.86, 3.04 (m, 
2H); 3.79 (m, 1H); 4.24 (m, 1H); 4.25, 4.30 (m, 2H); 6.87 (d, 3J = 6.63 Hz, 1H); 7.34 
(m, 2H); 7.42 (t, 2H); 7.71 (m, 2H); 7.89 (d, J = 7.9 Hz, 2H). 13C NMR (150.9 MHz, 
DMSO-d6): 33.4 (s), 47.1 (s), 50.5 (s), 50.8 (s), 66.2 (s), 120.6 (s), 125.7 (d), 127.6 
(s), 128.1 (s), 141.2 (s), 144.3 (s), 144.4 (s), 156.2 (s), 171.6 (s). MS: m/z 341 
[M+H]+. HRMS calculated for C19H21N2O4: 341.1496. Found 341.1510. []D20 
+870.95 (c 0.112, MeOH) 
11: FL-7292-43-1 1H NMR (600 MHz, CDCl3): 1.77 (br, 2H); 1.77-1.91 (br, 2H); 
2.62 (br, s, 3H); 2.94 (br, m, 2H); 4.14-4.24 (br, 1H); 4.01, 4.29 (br, 1H); 4.30-4.46 
(m, 2H); 7.26 (br, 2H); 7.35 (t, J = 7.92 Hz, 2H); 7.51 (br, 2H); 7.71 (d, J = 7.3 Hz, 
2H). 13C NMR (150.9 MHz, CDCl3): 21.9 (br), 28.0 (br), 33.3 (s), 47.1 (s), 49.2 (br), 
53.2 (s), 67.4 (s), 120.1 (s), 125.2 (br), 127.3 (s), 127.8 (s), 141.3 (s), 143.5 (s), 143.6 
(s), 156.8 (s), 175.0 (s).MS: m/z 369 [M+H]+. HRMS calculated for C21H25N2O4: 
369.1809. Found 369.1807. +331.17 (c 0.1264, MeOH)
Synthesis of 12 – 14:
Example of 12:
Crude 4 (0.146 mmol, 66 mg) was stirred in neat formic acid (0.5 mL) for 2 h 
followed by concentration under vacuo to form an oil. To this residue was added 
MeOH (2 mL) and 1,4-dioxane (6 drops) and aqueous formaldehyde (0.876 mmol, 
0.064 mL). The mixture turned milky. Sodium cyanoborohydride (0.31 mmol, 19.3 
mg, 2.1 eq) was then added in portions during 2 min. The mixture turned transparent 
and then back to milky. LCMS analysis of the reaction mixture revealed full 
conversion after 15 min and the mixture was concentrated under vacuo. To this 
residue was added triethylsilane (0.876 mmol, 0.14 mL), trifluoroacetic acid (0.14 
mL) and chloroform (0.14 mL) followed by heating for 8 h at 60 °C. LCMS analysis 
revealed full conversion of starting material and addition of a new single peak 
corresponding to the desired product 12. Yield 52 mg (97 %) with a purity >95 % 
(LCMS). Compounds 13 and 14 required 3 h at 100 °C for full conversion giving 
similar yields and purity in both cases. Lyophilisation from water/acetonitrile (1:1) 
yields a white powder of respective compound 12 - 14. The powders of compounds 
12 – 14 are air sensitive and become oils within minutes and thus requires N2 
atmosphere or cooled conditions for storage. 
12: FL_7292-50-1 1H NMR (600 MHz, CDCl3): 2.12, 2.33 (br, m, 2H); 2.74 (s, 3H); 
3.00, 3.19 (br, m, 2H); 4.07 (br, 1H); 4.25 (t, J = 6.88 Hz, 1H); 4.38 (m, 2H); 6.31 (br, 
1H); 7.35 (t, J = 7.60 Hz, 2H); 7.44 (t, J = 7.60 Hz, 2H); 7.65 (t, J = 6.66 Hz, 2H); 
7.80 (d, J = 7.29 Hz, 2H). 13C NMR (150.9 MHz, DMSO-d6): 29.3 (br), 44.2 (s), 47.1 
(s), 54.5 (s), 56.3 (s), 66.1 (s), 120.7 (s), 125.8 (s), 127.6 (s), 128.0 (s), 140.6 (s), 
141.4 (s), 144.3 (s), 150.0 (br), 173.7 (br). MS: m/z 369 [M+H]+. HRMS calculated 
for C21H25N2O4: 369.1809. Found 369.1796. []D20 +600.66 (c 0.15, CHCl3) 
13: FL-7292-64-1 1H NMR (600 MHz, CDCl3): 2.88 (s, 6H); 3.19, 3.38 (br, m, 2H); 
4.22 (m, 1H); 4.23 (m, 1H); 4.39 (m, 2H); 6.15 (br, s, 1H); 7.33 (t, J = 7.10 Hz, 2H); 
7.41 (t, J = 6.77 Hz, 2H); 7.61 (t, J = 6.09 Hz, 2H); 7.78 (d, J = 4.0 Hz, 2H). 13C NMR 
(150.9 MHz, CDCl3): 44 (br), 28.0 (br), 47.0 (s), 50.4 (s), 58.6 (s), 67.0 (s), 120.1 (s), 
125.0 (br), 127.3 (s), 127.8 (s), 141.2 (s), 141.3 (s), 143.6 (s), 143.9 (s), 156.0 (s), 
172.2 (s).MS: m/z 355 [M+H]+. HRMS calculated for C20H23N2O4: 355.1652. Found 
355.1641. []D20 +763.93 (c 0.118, CHCl3)
14: FL-7292-65-1 1H NMR (600 MHz, CDCl3): 1.67, 187 (m, 2H); 1.90 (m, 2H); 2.71 
(s, 6H); 2.81, 2.99 (m, 2H); 4.18 (m, 1H); 4.23 (t, J = 6.87 Hz, 1H); 4.32-4.38 (m, 
2H); 7.33 (m, 2H); 7.41 (m, 2H); 7.65 (m, 2H); 7.78 (d, J = 7.3 Hz, 2H). 13C NMR 
(150.9 MHz, CDCl3): 20.7 (s), 29.7 (s), 42.9 (s), 47.4 (s), 54.7 (s), 57.8 (s), 66.7 (s), 
120.0 (s), 125.2 (s), 125.3 (s), 127.0 (s), 127.6 (s), 141.3 (s), 144.0 (s), 144.2 (s), 
155.8 (s), 176.1 (s).MS: m/z 383 [M+H]+. HRMS calculated for C22H27N2O4: 
383.1965. Found 383.1977. []D20 +1161 (c 0.10, MeOH)
Synthesis of the Boc derivative of compound 9:
See literature procedure from Sakura et al.1 using compound 9 as starting material. 
Yield ~100%. 
1H NMR (600 MHz, CDCl3): 1.48 (br, s, 9H); 1.87, 2.25 (br, m, 2H); 2.66 (s, 3H); 
3.03, 3.83 (br, m, 2H); 4.23 (t, J = 7.23 Hz, 1H); 4.33 (br, m, 1H); 4.39 (br, m, 2H); 
6.19 (br, s, 1H); 7.31 (t, J = 7.59 Hz) 2H); 7.40 (t, J = 7.59 Hz, 2H); 7.61 (br, m, 2H); 
7.76 (d, J = 7.3 Hz, 2H). 13C NMR (150.9 MHz, CDCl3): 28.3 (s), 30.6 (s), 40.3 (s), 
44.9 (s), 47.0 (s), 51.3 (s), 66.9 (s), 81.6 (s), 119.9 (s), 125.3 (s), 127.1 (s), 127.7 (s), 
141.3 (s), 141.4 (s), 143.8 (s), 143.9 (s), 155.9 (s), 173.8 (br, s).
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